Clinical pilot study to find agreement between the respiratory rates obtained by raybaby with HCGs respiration monitor equipment (GE B30 patient monitor)
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- To check the agreement between the respiratory rates between the GE B30 and raybaby among adults, aging between 18 to 80 in the intensive care unit.
Study Overview
Brief Summary
This is an observational study to evaluate the effectiveness of Raybaby breathing monitor with respect to a medically certified device to assess the suitability of Raybaby non contact breath monitoring technique for clinical use. The study is yet to begin and publication would be drafted at the end of the study to establish correlation with medical standards and relevance.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18.00 Year(s) to 80.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •General ICU patients.
Exclusion Criteria
- •Patient with known lung issues.
Outcomes
Primary Outcomes
To check the agreement between the respiratory rates between the GE B30 and raybaby among adults, aging between 18 to 80 in the intensive care unit.
Time Frame: Respiratory rates (parameter of evaluation) from both devices will be compared at time intervals from 5 seconds or more and will be assessed post completion of monitoring of respective patients, starting from a minimum of 4 hour. Observations will be compiled every 2 weeks.
Secondary Outcomes
- To obtain usable respiration data with an average of 20% conversion rate from 4 to 10 hours of monitoring patients at periodic intervals of 5 minutes.